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The COVID-19 pandemic occurred in the metropole area of 
Wuhan in the Chinese province Hubei with a rapid dissemi-
nation of the virus worldwide [1, 2] leading to a pandemic 
[3]. After an increase of cases in Europe and Germany [4, 
5] warnings and recommendations to limit social contacts 
were issued. According to the fear of infection, there was a 
reduction of presentation in European and German emer-
gency departments [6], which might have led to a collateral 
damage of COVID-19 [6].
Most congresses like the congress of the European Soci-
ety of Cardiology, the American College of Cardiology 
and the German Cardiac Society were cancelled. Further-
more, there were travel restrictions by universities, industry 
and other healthcare institutions for doctors and scientists. 
Herein, we report the interesting consequence of travel 
restrictions and reductions of clinical and scientific meetings 
including smaller meetings like roundtables and advisory 
boards. During the three months of shutdown there was an 
increased submission rate of scientific manuscripts to Clini-
cal Research in Cardiology (Fig. 1a). This trend was stable 
over time and cannot be explained by an abnormal increase 
of submission rates to this Journal (Fig. 1b). In parallel, 
there was a shorter review time and shorter time to decision 
for acceptance or rejection of journal articles (Fig. 1c). As 
submissions in 50% of the cases come from other countries, 
the global shutdown had a positive effect of increased scien-
tific writing activities as well as of accelerated handling of 
scientific information. This observation cannot lead to the 
conclusion that a shutdown improves scientific quality or 
activity but it could be an indication that travel and meeting 
activities and scientific writing and publishing are compet-
ing for time of authors, reviewers, scientists and clinicians.
Herewith, the editors of Clinical Research in Cardiol-
ogy like to express their gratitude to all authors, review-
ers and staff of Springer Scientific Journals for putting so 
much effort in the generation of rapid review processes, high 
quality reviews and, thus, important contributions to clinical 
research and, thus, excellence in patient care.
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B Increase in monthly submissions between 01.2008 and 06.2020
C
Fig. 1  Submission rates of scientific manuscripts (a), submission rates over time in comparison to previous years (b) and time to final decision 
of acceptance or rejection (c) for Clinical Research in Cardiology
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as you give appropriate credit to the original author(s) and the source, 
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need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
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